Similar articles

• Embryo-fetal developmental toxicity study design for pharmaceuticals.

  Wise LD, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Lerman SA, Ooshima Y, Stump DG. Wise LD, et al. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):418-28. doi: 10.1002/bdrb.20214. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025038 Review.
• Pre- and postnatal developmental toxicity study design for pharmaceuticals.

  Bailey GP, Wise LD, Buschmann J, Hurtt M, Fisher JE. Bailey GP, et al. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):437-45. doi: 10.1002/bdrb.20217. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025040 Review.
• Developmental and reproductive toxicology studies in nonhuman primates.

  Chellman GJ, Bussiere JL, Makori N, Martin PL, Ooshima Y, Weinbauer GF. Chellman GJ, et al. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):446-62. doi: 10.1002/bdrb.20216. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025046 Review.
• The nonclinical fertility study design for pharmaceuticals.

  Lerman SA, Hew KW, Stewart J, Stump DG, Wise LD. Lerman SA, et al. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):429-36. doi: 10.1002/bdrb.20221. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025039 Review.
• Juvenile animal toxicity study designs to support pediatric drug development.

  Cappon GD, Bailey GP, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Ooshima Y, Stump DG, Hurtt ME. Cappon GD, et al. Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):463-9. doi: 10.1002/bdrb.20220. Birth Defects Res B Dev Reprod Toxicol. 2009. PMID: 20025047 Review.